Michael Johnston: RBS rolled out its fifth ETN this week, debuting a product that offers exposure to the world’s largest pharmaceutical firms. The new Global Big Pharma ETN (NYSE:DRGS) will seek to replicate Read more…

IHE, NYSE:DRGS, NYSE:PPH, PJP, XPH

Michael Johnston: So far, this year has been tough for markets around the globe. Since the downgrade of U.S. credit quality in August, equity markets have become plagued with rampant volatility, discouraging capital inflows and prompting many investors to pull out of the markets entirely. Just when the Read more…

NYSE:DFJ, NYSE:ENZL, NYSE:EWM, PJP, VPU

Jared Cummans: Pharmaceutical companies have long been popular investments as they offer relatively inelastic products as well as strong dividend yields that give both growth and value investors something to buy into. As far as the ETF world is concerned, there are four products that allow investors to gain Read more…

IHE, NYSE:PPH, PJP, XPH

Alex Strashny:  Recommended funds. Our main recommendation this week is real estate (NYSE:IYR). Its expected return jumped last week as it gained +4.46% in 5 days on slightly higher volume. However, its risk is high and has increased slightly. Because of the high risk in IYR, some Read more…

IBB, IYR, NYSE:EWM, PJP, SMH, XLE, XLU

Alex Strashny:  Recommended funds:  Biotech (NYSE:IBB) remains our primary recommendation this week. With the +1.68% rise and slightly higher volume over the past week, the expected return is definitely positive and slightly higher. IBB’s risk has decreased over the past week Read more…

IBB, IYR, NYSE:EWJ, NYSE:EWM, NYSE:GLD, PJP, SPY, XLE

The press is now talking about the swine flu again and it is putting a scare in the public sector. “In a recent report, the World Health Organization predicted that within two years nearly one-third of the world’s population will have contracted swine Read more…

IXJ, NYSE:PPH, PJP